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ST-segment Elevation Myocardial Infarction in North
African Women: Results From a Twenty-year
Experience
Ikram Chamtouri*, Rania Souissi, Nesrine Amdouni, Walid Jomaa, Wajih Abdallah,
Khaldoun B. Hamda, Faouzi Maatouk
Cardiology B Department, Fattouma Bourguiba University Hospital and University of Monastir, Tunisia

Abstract
Background: Coronary artery disease remains the most common cause of morbidity and mortality in the general
population. Several studies in developed countries have reported a gender-related difference in ST-segment elevation
myocardial infarction (STEMI) in terms of risk factors, clinical presentation, delays in management, therapeutic modalities, and in-hospital as well as one-year outcomes. Data from non-developed countries about women with STEMI
remain rare. We therefore aimed through this study to investigate the baseline characteristics of STEMI in Tunisian
women compared to men and to determine the impact of gender difference on STEMI complications, in-hospital
mortality, and one-year follow-up outcomes.
Methods: All patients presenting to our center for STEMI between January 2001 and January 2021 were retrospectively
enrolled in this analysis. Clinical features, therapeutic management, and in-hospital as well as one-year outcomes were
compared between women and men. Predictive factors of in-hospital mortality in women were determined.
Results: Out of 1670 STEMI hospitalizations, 359 (21.4%) were female. Compared to male, female had higher rates of
hypertension (51.5% vs. 24.4%, p < 0.001), diabetes (50.1% vs. 32.2%, p < 0.001), and obesity (63.8% vs. 55%, p ¼ 0.003). The
clinical presentation was characterized by less prevalent inaugural chest pain (58.8% vs. 68.6%, p < 0.001). Atypical
symptoms were signiﬁcantly higher in women compared to men (55.2% vs.5%, p < 0.001). On admission, women had higher
prevalence of anemia, renal failure, and hyperglycemia compared to men. Primary percutaneous coronary intervention
(pPCI) was the reperfusion strategy of choice in 37.9% of women vs. 33.1% of men (p ¼ 0.02). Women were signiﬁcantly less
likely to receive thrombolysis (p ¼ 0.004), with a signiﬁcantly less prevalent successful thrombolysis (55.6% vs. 67.2%,
p ¼ 0.013). In-hospital mortality was markedly higher in women compared to men (12.8% vs. 7.3%, p ¼ 0.001). Compared to
surviving women (n ¼ 313), those who died (n ¼ 46) frequently had more diabetes and hypertension (65.2% vs. 47.9%,
p ¼ 0.02 and 67.4%vs.49.2%, p ¼ 0.02, respectively). New-onset atrial ﬁbrillation, acute left heart failure, cardiogenic shock,
ventricular tachycardia, and atrioventricular block markedly occurred in women who died (52.2%vs. 23.3%, p¼<0.001;
17.4% vs. 1.9%, p < 0.001; 19.6% vs. 8.3%, p ¼ 0.016; 15.2% vs. 1.6%, p < 0.001 and 34.8% vs. 10.2%, p < 0.001, respectively).
Conclusion: Compared to men, Tunisian women presenting for STEMI had higher prevalence of risk factors and
atypical symptoms. Women had more in-hospital complications and mortality.
Keywords: STEMI, Women, Prognosis, Mortality

1. Introduction

C

oronary artery disease remains the most
common cause of morbidity and mortality in
the general population. About three million people

worldwide have myocardial infarction each year
[1,2]. In Tunisia, the age standardized incidence of
myocardial infarction was 163 per 100 000 people [3]
while this incidence ranged from 43 to 144 per
100 000 per year in European countries [4]. Several
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studies have reported a high prevalence of in-hospital complications and death in women presenting
with ST-elevation Myocardial Infarction (STEMI)
despite the marked improvements in revascularization strategies and secondary prevention [5e7].
Data from developed countries have shown that
women with STEMI tend to have worse in-hospital
outcomes, such as acute heart failure and higher inhospital mortality than men regardless of the
revascularization strategies (ﬁbrinolysis or primary
percutaneous coronary intervention (pPCI)) [8e11].
On the other hand, women with STEMI receive
reperfusion therapy less frequently compared to
men [12e14]. The contributing factors to gender gap
in terms of morbidity and mortality in patients with
STEMI remain unclear. Studies from undeveloping
countries focusing on the impact of gender difference on STEMI prognosis are rare [15]. This study
aimed to compare the baseline characteristics of
STEMI between Tunisian women and men and to
investigate the impact of gender difference on
STEMI complications, and in-hospital as well as one
year-follow-up outcomes.

2. Methods
2.1. Study population and design
Data were obtained from the STEMI registry at
the cardiology department. All patients presenting
with STEMI and admitted to our department between January 2001 and January 2021 were retrospectively enrolled in this study. STEMI was deﬁned
as a new ST-segment elevation> 2 mm in two
contiguous leads or a new left bundle branch block
on electrocardiogram (ECG), concomitant to prolonged chest pain >20 min [16]. The study population was divided into two groups according to
gender. Demographic data, cardiovascular risk factors, clinical presentation, delays, and electrocardiographic as well as biologic features were
collected and compared between the two groups.
The symptom-to-diagnosis delay was deﬁned as the
time from chest pain onset to STEMI diagnosis,
either in the emergency department or at the time of
the emergent medical service. Acute left heart failure on admission was deﬁned as Killip class II or III.
Cardiogenic shock was referred to as Killip class IV.
Acute right heart failure on admission was deﬁned
as the association of hypotension and jugular
venous distention or hepatojugular reﬂux. Renal
failure onadmission was deﬁned as a creatinine
clearance <60 mL/min using the Modiﬁcation of
Diet in Renal Disease (MDRD) formula in
patients with no chronic kidney disease history.
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Hyperglycemia on admission was deﬁned as glycemia 11 mmol/L. Anemia was deﬁned when the
hemoglobin rate was <13 g/dL in men and <12 g/dL
in women.
2.2. Therapeutic strategies and prognosis
Upon diagnosis, all patients received 250 mg of
aspirin, 100 IU of intravenous unfractionated heparin, and 300 mg or 600 mg oral dose of clopidogrel
according to the reperfusion strategy. The other
antiplatelets were not available in our center. The
choice of the reperfusion strategy, whether primary
percutaneous coronary intervention (pPCI) or
thrombolysis, was based on the availability of the
catheterization laboratory and the operator and the
possibility to transfer the patient to a PCI-capable
center within 90 min [15,16].
If not contraindicated, thrombolysis was started
immediately. Patients with contraindications to
thrombolysis were referred for pPCI, even when the
transfer time was delayed more than 120 min. The
decision not to offer any reperfusion strategy was
made based on individual criteria, such as advanced
age, severe co-morbidities, late presentation, or
contraindications to both reperfusion methods.
Spontaneous reperfusion was deﬁned as the disappearance of chest discomfort concomitant with
complete ST-segment regression before the initiation of reperfusion therapy. Diagnosis to pPCI delay
was deﬁned as the time from STEMI diagnosis to
successful wire crossing time during PPCI. Diagnosis-to-ﬁbrinolysis delay was deﬁned as the time
from STEMI diagnosis to ﬁbrinolysis administration.
Thrombolysis success was deﬁned by a regression
>50% of ST segment in the ECG lead with maximal
ST elevation, and/or disappearance of chest pain
with no hemodynamic or electrical instability
60e90 min after the initiation of thrombolysis [17]. At
discharge, all patients received aspirin and statins
for life and clopidogrel for 1e12 months. Betablockers and angiotensin-converting enzyme inhibitors were prescribed according to the indication.
The primary outcome measure was in-hospital
complications, including acute left and right heart
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failure, cardiogenic shock, conduction and rhythm
troubles, mechanical complications, acute pericarditis effusion, hemorrhage, and mortality. Secondary outcomes, including rehospitalization, acute
coronary artery syndrome, and death were reported
at the one year follow-up. Univariate analysis was
performed to determine the appropriate factors
associated with in-hospital death in women. Factors
independently associated with in-hospital death in
women were studied in multivariate analysis.
2.3. Statistical analysis
Categorical variables were presented as absolute
value sand proportions. The independent t-test
and Chi-square test were used to compare means
and proportions of continuous and categorical
variables, respectively. Multivariate analysis was
performed using binary logistic regression for
variables that were signiﬁcantly associated with inhospital death in univariate analysis. Multivariable
adjusted odds ratio (OR) with accompanying
95% conﬁdence intervals were reported. A p
value < 0.05 was set for statistical signiﬁcance.
Statistical analyses were performed using Statistical Package for Social Sciences (SPSS), version 21
(IBM, Armonk, NY, USA).

3. Results
3.1. Patients’ demographic characteristics, clinical
presentation, and electrocardiographic as well as
biologic ﬁndings on admission (Table 1)
Out of 1670 STEMI hospitalizations, 359 (21.4%)
were women. The proportion of patients aged >65
years was 39.9% and that of young women (<40
years) was 2.5%. Diabetes mellitus, hypertension,
current smoking, and obesity accounted for 35.9%,
30.1%, 66.8%, and 56.7%, respectively. Compared to
men, women had higher rates of hypertension,
diabetes, and obesity. Smoking was less prevalent in
women compared to men. History of percutaneous
coronary intervention (PCI) and chronic heart failure was more frequent in women. Nevertheless, no
signiﬁcant difference was noted between the two
genders with regard to hyperlipidemia, coronary
artery bypass grafting (CABG), and peripheral
arterial disease of the lower extremities. The clinical
presentation was characterized by a less prevalent
inaugural chest pain. Atypical symptoms, including
gastrointestinal complains, fatigue, dyspnea, or
atypical irradiation were signiﬁcantly higher in
women compared to men. Moreover, tachycardia
>100 bpm was more frequent in women compared

Table 1. Baseline characteristics according to gender.

Age 65 years
Age<40 years
Diabetes mellitus
Hypertension
Hyperlipidemia
Current smoking
Obesity (BMI>30)
Prior chronic coronary syndrome
Prior chronic heart failure
Prior PCI
Prior CABG
Peripheral artery disease of the lower extremities
Clinical presentation on admission
Inaugural chest pain
Atypical presentation
Symptoms -to- diagnosis delay >1 h
Tachycardia >100 bpm on admission
SBP >140
Electrocardiographic and biological results on admission
Anterior location of STEMI
ST segment elevation on AvR
ST segment elevation on V3R and V4R
Anemia on admission
Serum creatinine level on admission >120 mmol/L
Hyperglycemia on admission

Population
(n ¼ 1670)

Female gender
(n ¼ 359)

Male gender
(n ¼ 1311)

p

600 (40.1%)
104 (6.2%)
602 (36%)
505 (30.2%)
197 (11.8%)
1119 (67%)
950 (56.9%)
114 (6.8%)
37 (2.2%)
137 (8.2%)
6 (0.4%)
58 (3.4%)

191 (53.2%)
9 (2.5%)
180 (50.1%)
185 (51.5%)
52 (14.5%)
87 (24.2%)
229 (63.8%)
45 (12.5%)
13 (3.6%)
75 (20.9%)
3 (0.8%)
12 (3.3%)

478 (36.5%)
95 (7.2%)
422 (32.2%)
320 (24.4%)
145 (11.1%)
1032 (78.7%)
721 (55%)
69 (5.3%)
24 (1.8%)
62 (4.7%)
3 (0.2%)
46 (3.5%)

<0.001
<0.001
<0.001
<0.001
0.07
<0.001
0.003
<0.001
0.04
<0.001
0.008
0.8

1110 (66.5%)
263 (15.7%)
1284 (76.9%)
293 (17.5%)
292 (17.5%)

211 (58.8%)
198 (55.2%)
313 (87.2%)
76 (21.2%)
64 (17.8%)

899 (68.6%)
65 (5%)
971 (74.1%)
217 (16.6%)
228 (17.4%)

<0.001
<0.001
<0.001
0.04
0.8

823
111
162
386
315
587

174 (48.5%)
32 (8.9%)
25 (7%)
139 (38.7%)
80 (22.3%)
164 (45.7%)

649 (49.5%)
79 (6%)
137 (10.5%)
247 (18.8%)
235 (17.9%)
423 (32.3%)

0.2
0.04
0.06
<0.001
0.06
<0.001

(49.3%)
(6.6%)
(9.7%)
(23.1%)
(18.9%)
(35.1%)

BMI: body mass index, CABG: Coronary artery bypass grafting, pPCI: Primary percutaneous coronary intervention, SBP, systolic blood
pressure, STEMI: ST-segment elevation myocardial infarction.

to men on admission. Symptoms -to- diagnosis
delay >1 hour was signiﬁcantly more prevalent
among women irrespective of whether they arrived
by ambulance or they presented by themselves. No
sex difference was noted in the prevalence of anterior ST-elevation location. Nevertheless, ST
segment elevation in AvR was signiﬁcantly higher in
women. Biologic parameters on admission demonstrated higher prevalence of anemia, renal failure,
and hyperglycemia in women compared to men.
3.2. Therapeutic strategies in the acute phase of
STEMI (Table 2)
Percutaneous coronary intervention (pPCI) was
the reperfusion strategy of choice in 37.9% of
women vs. 33.1% of men (p ¼ 0.02). Diagnosis to
pPCI delay>2 h was numerically less prevalent in
women. However, diagnosis to thrombolysis delay
>2 h was signiﬁcantly more prevalent in women.
The latter were signiﬁcantly less likely to receive
thrombolysis (p ¼ 0.004), with a signiﬁcantly less
prevalent thrombolysis success (55.6% vs. 67.2%;
p ¼ 0.013). Prevalence of conservative medical
treatment and spontaneous ﬁbrinolysis was similar
between the two genders. Left coronary artery was
the most culprit artery in both genders, with a signiﬁcant higher prevalence in women (p < 0.001).
Moreover, women more often multi-vessel stenosis
(p ¼ 0.008) and presented a markedly higher prevalence of spontaneous coronary dissection
(p < 0.001). No signiﬁcant difference was noted in

non-obstructive coronary arteries between the two
genders.
3.3. In-hospital and one-year outcomes and
mortality (Tables 3 and 4)
Compared to men, new-onset acute left and right
heart failure was more prevalent in women (p ¼ 0.01
and p < 0.001, respectively). A total of 344 patients
with no preexisting heart failure experienced new
onset of acute left heart failure without signiﬁcant
difference between the two sex (p ¼ 0.051). Second
or third degree atrioventricular blocks were signiﬁcantly higher in women compared to men
(p ¼ 0.008) but with no effect of culprit artery or
STEMI territories on this complication in women
(right coronary artery 33.3%, inter ventricular artery
20.8% and other arteries 45.9%, p ¼ 0.2). New-onset
atrial ﬁbrillation was more frequent in women
(p ¼ 0.006). Nevertheless, no differences in terms of
sustained ventricular tachycardia, cardiogenic
shock, mechanical complications, and hemorrhage
were noted between the two genders. A higher rate
of ventricular tachycardia, ventricular ﬁbrillation,
acute left heart failure and cardiogenic shock (3.9%,
5.1%, 30.6% and 3.3% respectively) was noted in
anterior location of STEMI. In-hospital mortality
rate was markedly higher in women than in men
(12.8% vs. 7.3%, p ¼ 0.001). The one-year follow-up
revealed less rehospitalization and acute coronary
artery diseases in women compared to men, with no
signiﬁcant difference in mortality.

Table 2. Therapeutic strategies and angiographic results according to gender.

pPCI
Diagnosis to pPCI delay >2 h
Thrombolysis
Diagnosis to thrombolysis delay >2 h
Thrombolysis success
Spontaneous ﬁbrinolysis
Conservative treatment
GPIIbIIIa antagonist use
Culprit coronary artery
AIVA
CxA
RCA
MgA
DgA
non-obstructive coronary arteries
Spontaneous coronary dissection
Multi-vessel stenoses

Population
(n ¼ 1670)

Female
(n ¼ 359)

Male
(n ¼ 1311)

p

570 (34.1%)
434 (75.6%)
578 (34.6%)
413 (71.5%)
514 (65.4%)
189 (11.3%)
497 (29.8%)
136 (8.2%)
600 (35.9%)
291 (17.4%)
520 (31.1%)
143 (8.6%)
72 (4.3%)
44 (2.6%)
6 (0.4%)
74 (4.4%)

136 (37.9%)
96 (70.1%)
101 (28.1%)
84 (83.2%)
69 (55.6%)
35 (9.7%)
112 (31.2%)
27 (7.5%)
109 (30.4%)
74 (20.6%)
98 (27.3%)
56 (15.6%)
16 (4.5%)
6 (1.7%)
5 (1.4%)
25 (7%)

434 (33.1%)
338 (77.3%)
477 (36.4%)
329 (69%)
445 (67.2%)
154 (11.7%)
385 (39.4%)
109 (8.3%)
491 (37.5%)
217 (16.6%)
422 (32.2%)
87 (6.6%)
56 (4.3%)
38 (2.9%)
1 (0.1%)
49 (3.7%)

0.02
0.08
0.004
0.004
0.013
0.3
0.2
0.6
<0.001

0.2
<0.001
0.008

AIVA: anterior inter ventricular artery, CxA: circumﬂex artery, DgA: diagonal artery, MgA: marginal artery, pPCI: Primary percutaneous
coronary intervention, RCA: right coronary artery, STEMI: ST-segment elevation myocardial infarction.

ORIGINAL ARTICLE

169

JOURNAL OF THE SAUDI HEART ASSOCIATION 2022;34:166e174

170

JOURNAL OF THE SAUDI HEART ASSOCIATION 2022;34:166e174

ORIGINAL ARTICLE

Table 3. In-hospital prognosis according to gender.
New onset acute left heart failure
New onset right heart failure
Cardiogenic shock
New onset atrial ﬁbrillation
Ventricular tachycardia
Ventricular ﬁbrillation
Second or third atrioventricular block
Pericardial effusion
Mechanical complications
Hemorrhage
In-hospital mortality

Population (n ¼ 1670)

Female (n ¼ 359)

Male (n ¼ 1311)

p

368 (22%)
66 (4%)
47 (2.8%)
110 (6.6%)
60 (3.6%)
65 (3.9%)
154 (9.2%)
60 (3.6%)
8 (0.5%)
44 (2.6%)
142 (8.5%)

97 (27%)
19 (5.3%)
14 (3.9%)
35 (9.7%)
12 (3.3%)
16 (4.5%)
48 (13.4%)
16 (4.5%)
2 (0.6%)
8 (2.2%)
46 (12.8%)

271 (20.7%)
47 (3.6%)
33 (2.5%)
75 (5.7%)
48 (3.7%)
49 (3.7%)
106 (8.1%)
44 (3.4%)
6 (0.5%)
36 (2.7%)
96 (7.3%)

0.01
<0.001
0.16
0.006
0.7
0.5
0.008
0.35
0.8
0.5
0.001

Table 4. One-year follow-up according to gender.
Rehospitalization
Acute coronary syndrome
Death

Population (n ¼ 1528)

Female (n ¼ 313)

Male (n ¼ 1215)

p

432 (25.9%)
53 (3.2%)
38 (2.5%)

72 (20.1%)
6 (1.7%)
4 (1.3%)

360 (27.5%)
47 (3.6%)
34 (2.8%)

0.001
0.001
0.1

Predictive factors of in-hospital mortality in
women were studied in univariate analysis (Table 5).
Diabetes and hypertension (65.2%vs. 47.9%, p ¼ 0.02
and 67.4%vs. 49.2%, p ¼ 0.02, respectively) were
more frequent in women who died (n ¼ 46)
compared to those surviving (n ¼ 313). Paradoxically,
current smoking was signiﬁcantly lower in those
who died than in survivors. Anemia and renal failure

on admission were signiﬁcantly more prevalent in
women who died. New-onset atrial ﬁbrillation, acute
left heart failure, cardiogenic chock, ventricular
tachycardia, and atrioventricular block were markedly noted in those who died (52.2%vs. 23.3%,
p¼<0.001, 17.4% vs. 1.9%, p < 0.001, 19.6% vs. 8.3%,
p ¼ 0.016, 15.2% vs. 1.6%, p < 0.001, and 34.8% vs.
10.2%, p < 0.001 respectively). Multivariate analysis

Table 5. Factors associated with in-hospital death in women in univariate analysis.
Age 65 years
Diabetes mellitus
Hypertension
Current smoking
Obesity (BMI>30)
Prior heart failure
Prior PCI
Symptoms -to- diagnosis delay >1 h
Tachycardia >100 bpm on admission
Anemia on admission
Serum creatinine level on admission >120 mmol/L
Hyperglycemia on admission
pPCI
Diagnosis to pPCI delay >2 h
Thrombolysis
Diagnosis to thrombolysis delay >2 h
Spontaneous ﬁbrinolysis
GPIIbIIIa antagonist recourse
Acute left heart failure on admission
Cardiogenic shock
New onset atrial ﬁbrillation
Ventricular tachycardia
Atrioventricular block

Survivors (n ¼ 313)

dead (n ¼ 46)

P

158 (50.5%)
150 (47.9%)
154 (49.2%)
84 (26.8%)
200 (63.9%)
11 (3.5%)
72 (23%)
276 (88.2%)
60 (19.2%)
104 (33.2%)
57 (18.2%)
139 (44.4%)
117 (37.4%)
80 (67.8%)
89 (28.4%)
75 (84.4%)
32 (10.2%)
17 (5.4%)
73 (23.3%)
6 (1.9%)
26 (8.3%)
5 (1.6%)
32 (10.2%)

33 (71.7%)
30 (65.2%)
31 (67.4%)
3 (6.5%)
29 (63%)
2 (4.3%)
3 (6.5%)
37 (80.4%)
16 (34.8%)
35 (76.1%)
23 (50%)
25 (54.3%)
19 (41.3%)
16 (84.2%)
12 (26.1%)
9 (75%)
3 (6.5%)
10 (21.7%)
24 (52.2%)
8 (17.4%)
9 (19.6%)
7 (15.2%)
16 (34.8%)

0.007
0.02
0.02
0.003
0.9
0.6
0.03
0.1
0.016
<0.001
<0.001
0.2
0.6
0.1
0.7
0.4
0.4
<0.001
<0.001
<0.001
0.016
<0.001
<0.001

BMI: body mass index, pPCI: primary percutaneous coronary intervention.

Table 6. Factors independently associated with in-hospital mortality in
women presenting with ST-elevation myocardial infarction (STEMI) in
multivariate analysis.
Variables

Odds ratio

95% CI

p

Tobacco
Tachycardia >100
New onset acute heart failure
Cardiogenic shock
Atrial ﬁbrillation

0.2
2.025
2.008
17.32
1.93

0.04e0.87
0.83e4.92
0.89e4.52
7.57e39.61
0.63e5.92

0.03
0.12
0.09
<0.001
0.25

revealed that cardiogenic shock was independently
associated with in-hospital mortality in women
(OR ¼ 17.32, 95% CI: 7.57e39.61, p < 0.001) (Table 6).

4. Discussion
Coronary artery disease is the most common
cause of mortality in both men and women worldwide [16]. Despite its decreasing incidence, STEMI
remains more common in men than in women [18].
During STEMI, gender difference in terms of cardiovascular proﬁle, clinical presentation, therapeutic modalities, and prognosis has been widely
studied. Several studies in developed countries have
highlighted the poor outcome in women with
STEMI [19e21]. However, data about this issue are
limited in undeveloped countries. To the best of the
authors’ knowledge, this is the ﬁrst and the largest
Tunisian study investigating gender difference
during STEMI. As reported in previous studies, a
difference in cardiovascular risk proﬁle was noted
between women and men, making women more
susceptible to STEMI [22e24]. Among the cardiovascular risk factors, old age, diabetes, and hypertension are the leading factors for STEMI in women
[25]. These results are consistent with those found in
the present study, revealing higher prevalence of
diabetes and hypertension, and lower prevalence of
smoking in women with STEMI [26,27]. Delay in
seeking care is one of the principal factors for a bad
prognosis in women with STEMI [28e30]. Women
tend to seek medical care later than men because of
many factors, such as the lack of health awareness,
psychosocial factors, lack of recognition of alarming
symptoms, and the difﬁculty to access to health care
services [31,32]. Such behavior could delay STEMI
diagnosis and appropriate therapeutic strategy, thus
leading to a bad prognosis. However, in the present
study, symptoms-to-diagnosis delay did not affect
hospital mortality rate in women. As reported in
other studies [33,34], our results revealed that chest
pain was the most common symptom for both
women and men. However, women are more likely
to have a greater variety of symptoms, including
back or epigastric pain, which they most often

171

misinterpret compared to men. Atypical symptom
recognition affects not only the delay in seeking care
but also the prognosis [35]. Regarding the therapeutic strategies, the guidelines recommend that
both men and women receive the same STEMI
management [36]. Despite the higher bleeding
complications and mortality in women as reported
in the ISIS-3 study (36080 STEMI patients treated by
ﬁbrinolysis), women should beneﬁt from thrombolytic therapy when pPCI is not available [37].
Nevertheless, several studies have reported worse
outcomes and higher mortality in women compared
to men after pPCI in STEMI [38,39]. These results
could be attributed to older age, higher cardiovascular and comorbidities prevalence, and longer
symptom-to-balloon time [40,41]. In accordance
with our results, a multicentric Australian study
reported lower prevalence of pPCI in women
compared to men [42]. However, the results of the
aforementioned study are not in accordance with
those found in the present study, revealing no
impact of both thrombolysis and pPCI on in-hospital mortality. In our study, the low rate of pPCI
could be explained by the non availability of the
cath laboratory during the ﬁrst three years of the
study. So thrombolysis was the reperfusion strategy
of choice at that period. The time door to ballon is
often long leading to the use of ﬁbrinolysis as well as
many patients received thrombolysis at the ambulance even before the arrival at the hospital. Inhospital prognosis in women with STEMI remains
poor with a higher mortality rate. Previous studies
have revealed that women with STEMI have higher
in-hospital mortality compared to men [43e45].
However, one-year and long-term mortality is
controversial. Pascual reported that gender difference is not a risk factor for one-year mortality in
STEMI patients [46], which was supported by the
present study results. However, other reports have
revealed higher one-year mortality in women
compared to men, which is explained by the worse
clinical proﬁle and the reduced rate of reperfusion
therapy [47e49].
4.1. Study limitations
The present study presents several limitations,
including the retrospective observational study
type. Our registry included only patients admitted
to one Tunisian tertiary care center. So, data could
not be adapted to all the Tunisian population. The
reduced number of women could explain the weak
statistical relationship between some factors
(reperfusion therapies, in-hospital prognosis). In
addition, the study did not take into consideration
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the thrombolytic type, and the stenting procedure
and complications. Moreover, the follow-up time
was limited to one year. Information on chronic
medical treatment during the follow-up and the
echocardiographic evaluation were not assessed.

[5]

5. Conclusion

[6]

Gender-difference in terms of in-hospital prognosis between women and men with STEMI is due
to the difference in the patients’ characteristics (age
and cardiovascular risk factors). Sex-related pathophysiological differences may contribute to the
higher in-hospital mortality and complications in
women compared to men. At one-year follow-up,
the prognosis is reversed to poor outcomes (rehospitalization and acute coronary artery events) in
men with STEMI with no difference in mortality
between the two genders.
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